Your browser doesn't support javascript.
loading
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer.
Lorente, David; Castro, Elena; Lozano, Rebeca; Puente, Javier; Romero-Laorden, Nuria; Rodríguez-Vida, Alejo; Lainez, Nuria; Villatoro, Rosa; Llácer, Casilda; Cattrini, Carlo; Hernández, Amaia; Domenech, Montserrat; Zambrana, Francisco; Almagro, Elena; Luque, Raquel; Martinez, Esther; López-Campos, Fernando; Gonzalez, Belen; Méndez-Vidal, Maria Jose; Medina, Ana; Piulats, Josep Maria; Olmos, David.
Afiliação
  • Lorente D; Servicio de Oncología Médica, Hospital Provincial de Castellón, Castellón de la Plana, Spain; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain. Electronic address: dlorenteestelles@seom.org.
  • Castro E; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional d
  • Lozano R; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain.
  • Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.
  • Romero-Laorden N; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario La Princesa, Madrid, Spain.
  • Rodríguez-Vida A; Hospital del Mar, Barcelona, Spain.
  • Lainez N; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Villatoro R; Hospital Universitario Costa del Sol, Marbella, Spain.
  • Llácer C; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
  • Cattrini C; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Academic Unit of Medical Oncology, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
  • Hernández A; Onkologikoa-Instituto Oncológico, Donostia, Spain.
  • Domenech M; Fundació Althaia Manresa, Manresa, Spain.
  • Zambrana F; Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain.
  • Almagro E; Hospital Universitario Quirón, Madrid, Spain.
  • Luque R; Complejo Hospitalario Universitario de Granada, Granada, Spain.
  • Martinez E; Hospital Universitario de Jaén, Jaén, Spain.
  • López-Campos F; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Gonzalez B; Hospital de Son Llatzer, Palma de Mallorca, Spain.
  • Méndez-Vidal MJ; Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Medina A; Centro Oncológico de Galicia, A Coruña, Spain.
  • Piulats JM; Institut Catalá d'Oncologia, Hospitalet de Llobregat, Spain.
  • Olmos D; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain.
Eur Urol ; 77(6): 763-766, 2020 06.
Article em En | MEDLINE | ID: mdl-32143923
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article